There have also been advances in technology that make it more accessible and affordable for health systems to incorporate into their cancer programs. This is a critical advancement as we strive to ensure the treatment is available to patients who need it the most.

Another key milestone is the growing body of clinical evidence demonstrating the efficacy and value of proton therapy for a variety of cancer types. As more leading academic centers including NCCN and NCI designated comprehensive cancer centers adapt this technology, the research supporting its value becomes more robust.


There has also been an increase in collaborations and partnerships between proton therapy centers and other healthcare providers, which has helped develop and refine proton therapy techniques and protocols.

In the meantime, there has been a growing awareness of proton therapy among patients and the general public, which has helped increase access to this treatment option and improve patient outcomes.

EN: The last couple of years have been an exciting time in proton therapy as we have activated and treated many patients on clinical trials aimed to help prove the role and benefit of proton therapy. We have had data come out supporting the use of proton therapy in oropharynx cancers as well as esophageal cancers to start with a view and the newer cancer guidelines continue to expand the recommendations for proton therapy.

From a technology viewpoint, we are now able to offer the same image guidance as we do in photon therapy and there is on-going research to develop proton arc therapy as well as other techniques to treat our patients.

On a research front, there continues to be exciting work looking at the use of FLASH radiotherapy with a recent clinical trial completed delivering this therapy to patients with bone metastasis.

Lastly, as more proton therapy centers have opened, we've really been able to expand the access of this technology to more and more patients although there is still more work to be done. Thankfully, groups like NAPT have made this mission a priority.

HCB News: What's been happening with reimbursement?

Rad Oncology Homepage